Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...
Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...
Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...
Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co...
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...
Singapore: Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development ...
Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment o...
Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the nex...
Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (ad...
Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have join...
Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...
Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2...
Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides si...
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...
Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggerin...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from ...
Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understa...
Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design...
Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab,...
Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular...
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have c...
Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Dru...
Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational ...
Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered i...
Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk ...
Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine...
Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel a...
Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to ...
Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insuli...
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...
Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed t...
Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Therav...
Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...
Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...
Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process ...
Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to mu...
Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...
Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk ann...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal...
Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel...
Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...
Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...
Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of n...
Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Cou...
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...
Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood Ci...
Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely ...
Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new dr...
Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across d...
Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...
Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltr...
Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...
Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research pr...
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...
Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neo...
Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for ...
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, rec...
Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithK...
Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corpora...
Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out r...
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...
Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory...
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...
Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a bi...
Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board...
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...
Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval ...
Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Applicat...
Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobi...
Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 ki...
Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...
Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...
Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...
Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...
Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...
Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...
Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, whi...
Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is r...
Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) ...
Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Ch...
Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Healt...
Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for...
Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the mi...
Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, ...
Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustai...
Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cance...
Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]...
